|
DHX40 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.33146835171283E-15 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.24910131921774E-11 |
| Normal-vs-Stage2 |
1.436130E-03 |
| Normal-vs-Stage3 |
3.263600E-03 |
| Normal-vs-Stage4 |
1.765740E-02 |
| Stage1-vs-Stage2 |
8.160400E-01 |
| Stage1-vs-Stage3 |
5.724000E-01 |
| Stage1-vs-Stage4 |
1.004630E-01 |
| Stage2-vs-Stage3 |
5.394600E-01 |
| Stage2-vs-Stage4 |
2.611400E-01 |
| Stage3-vs-Stage4 |
1.073210E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.1863400806742E-14 |
| Normal-vs-AfricanAmerican |
2.82250000038786E-07 |
| Normal-vs-Asian |
1.448630E-01 |
| Caucasian-vs-AfricanAmerican |
6.622200E-01 |
| Caucasian-vs-Asian |
6.618200E-01 |
| AfricanAmerican-vs-Asian |
7.502800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.43693953905222E-13 |
| Normal-vs-Female |
1.12080000835846E-09 |
| Male-vs-Female |
3.558400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.799800E-04 |
| Normal-vs-Extreme_Weight |
2.11270000050057E-07 |
| Normal-vs-Obese |
1.08509999985351E-07 |
| Normal-vs-Extreme_Obese |
4.347500E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.790200E-01 |
| Normal_Weight-vs-Obese |
5.939800E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.962400E-01 |
| Extreme_Weight-vs-Obese |
4.913600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.831000E-01 |
| Obese-vs-Extreme_Obese |
7.423800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.38780000000527E-06 |
| Normal-vs-Age(41-60Yrs) |
9.99200722162641E-16 |
| Normal-vs-Age(61-80Yrs) |
7.40469999760407E-08 |
| Normal-vs-Age(81-100Yrs) |
2.442400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.821200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.625700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.016000E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.965500E-04 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.091800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.487800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.6242562850266E-12 |
| Normal-VS-Type2 PRCC |
9.698400E-03 |
| Normal-VS-KIRP CIMP |
6.917500E-03 |
| Normal-VS-Unclassified PRCC |
9.79410000000458E-05 |
| Type1 PRCC-VS-Type2 PRCC |
1.87929999999614E-05 |
| Type1 PRCC-VS-KIRP CIMP |
8.902000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.600600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.198000E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.532400E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.009000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.042100E-04 |
| Normal-vs-N1 |
1.236740E-03 |
| Normal-vs-N2 |
9.702100E-02 |
| N0-vs-N1 |
9.985500E-02 |
| N0-vs-N2 |
1.963810E-02 |
| N1-vs-N2 |
4.645800E-01 |
|
|
